DalsnaFinance › IPOs › Atea Pharmaceuticals Inc › IPO
Atea Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on October 30, 2020, pricing at $24.00 a share.
| Ticker | AVIR |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 30, 2020 |
| Offering price | $24.00 |
| Shares offered | 12,500,000 |
| Total raised | $300M |
Atea Pharmaceuticals, Inc. sold 12,500,000 shares at $24.00 each on NASDAQ. Multiplied out, that is $300 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $300 million total recorded for the deal.
Atea Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Atea Pharmaceuticals, Inc.. This page is general information, not investment advice.